Regencell Bioscience Holdings (RGC) Balance Sheet Annual - Discounting Cash Flows
Regencell Bioscience Holdings Limited
RGC (NASDAQ)

* (except for per share items) of USD
Period Ending: 2023
06-30
2022
06-30
2021
06-30
2020
06-30
2019
06-30
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-26
2012
12-27
2010
12-30
2009
12-31
2008
12-31
2007
12-27
2006
12-28
2004
12-30
2003
12-31
2002
12-26
Report Filing: 2023-10-27 2022-10-31 2021-10-29 2020-06-30 2019-06-30 2018-03-01 2017-02-27 2016-02-29 2015-03-02 2014-02-24 2013-02-25 2011-02-28 2010-03-01 2009-03-02 2008-02-26 2007-02-26 2005-03-15 2004-03-16 2003-03-26
Total Current Assets
Cash and Short Term Investments
Cash & Equivalents
Short Term Investments
Receivables
Inventory
Other Current Assets
Total Assets
Total Non-Current Assets
Property, Plant and Equipment
Goodwill and Intangible Assets
Goodwill
Intangible Assets
Long Term Investments
Deferred Tax Assets
Other Long Term Assets
Total Current Liabilities
Accounts Payable
Notes Payable/Short Term Debt
Tax Payables
Deferred Revenue
Other Current Liabilities
Total Liabilities
Total Non-Current Liabilities
Total Long Term Debt
Deferred Tax Liabilities Non-Current
Deferred Revenue Non-Current
Capital Lease Obligations
Other Long Term Liabilities
Total Equity
Non-Controlling Interest
Total Stockholders' Equity
Retained Earnings
Accumulated Other Earnings
Common Stock
Preferred Stock
Additional Paid in Capital
Total Liabilities & Total Equity
Total Liabilities & Shareholders' Equity
Total Investments
Total Debt
Net Debt
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us